最近搜索:細胞培養 微生物學 分子生物 生物化學
    首頁>>免疫學>>一抗>>磷酸化細胞核因子p50/k基因結合核因子抗體
    磷酸化細胞核因子p50/k基因結合核因子抗體
    • 產品貨號:
      BN41114R
    • 中文名稱:
      磷酸化細胞核因子p50/k基因結合核因子抗體
    • 英文名稱:
      Rabbit anti-Phospho-NFKB1 (Ser903) Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產品規格

      售價

      備注

    • BN41114R-100ul

      100ul

      ¥2470.00

      交叉反應:Human 推薦應用:IHC-P,IHC-F,IF,Flow-Cyt,ELISA

    產品描述

    英文名稱Phospho-NFKB1 (Ser903)
    中文名稱磷酸化細胞核因子p50/k基因結合核因子抗體
    別    名NFkB p105 / p50 (phospho S903); DKFZp686C01211; DNA binding factor KBF1; DNA binding factor KBF1 EBP1; DNA binding factor KBF1 EBP1; DNA-binding factor KBF1; EBP 1; EBP-1; EBP1; KBF1; MGC54151; NF kappa B; NF kappabeta; NF kB1; NFKB 1; NFKB p105; NFKB p50; NFKB1; NFKB1_HUMAN; Nuclear factor kappa B DNA binding subunit; Nuclear factor NF kappa B p105 subunit; Nuclear factor NF kappa B p50 subunit; Nuclear factor NF-kappa-B p50 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; p84/NF-kappa-B1 p98.  
    產品類型磷酸化抗體 
    研究領域腫瘤  細胞生物  免疫學  染色質和核信號  信號轉導  細胞凋亡  轉錄調節因子  表觀遺傳學  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應Human, 
    產品應用ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 (石蠟切片需做抗原修復)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量105kDa
    細胞定位細胞核 細胞漿 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated Synthesised phosphopeptide derived from human NF KappaB p105 around the phosphorylation site of Ser903:AH(p-S)LP 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產品介紹This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. SUBUNIT: Active NF-kappa-B is a heterodimer of an about 50 kDa DNA-binding subunit and the weak DNA-binding subunit p65. Two heterodimers might form a labile tetramer. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL.

    Function:
    This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].

    Subunit:
    Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-p50 complex. Homodimer; component of the NF-kappa-B p50-p50 complex. Component of the NF-kappa-B p105-p50 complex. Component of the NF-kappa-B p50-c-Rel complex. Component of a complex consisting of the NF-kappa-B p50-p50 homodimer and BCL3. Also interacts with MAP3K8. NF-kappa-B p50 subunit interacts with NCOA3 coactivator, which may coactivate NF-kappa-B dependent expression via its histone acetyltransferase activity. Interacts with DSIPI; this interaction prevents nuclear translocation and DNA-binding. Interacts with SPAG9 and UNC5CL. NFKB1/p105 interacts with CFLAR; the interaction inhibits p105 processing into p50. NFKB1/p105 forms a ternary complex with MAP3K8 and TNIP2. Interacts with GSK3B; the interaction prevents processing of p105 to p50. NFKB1/p50 interacts with NFKBIE. NFKB1/p50 interacts with NFKBIZ. Nuclear factor NF-kappa-B p50 subunit interacts with NFKBID. Directly interacts with MEN1. Interacts with HIF1AN.

    Subcellular Location:
    Nucleus. Cytoplasm. Note=Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B).

    Post-translational modifications:
    While translation occurs, the particular unfolded structure after the GRR repeat promotes the generation of p50 making it an acceptable substrate for the proteasome. This process is known as cotranslational processing. The processed form is active and the unprocessed form acts as an inhibitor (I kappa B-like), being able to form cytosolic complexes with NF-kappa B, trapping it in the cytoplasm. Complete folding of the region downstream of the GRR repeat precludes processing.
    Phosphorylation at 'Ser-903' and 'Ser-907' primes p105 for proteolytic processing in response to TNF-alpha stimulation. Phosphorylation at 'Ser-927' and 'Ser-932' are required for BTRC/BTRCP-mediated proteolysis.
    Polyubiquitination seems to allow p105 processing.
    S-nitrosylation of Cys-61 affects DNA binding.
    The covalent modification of cysteine by 15-deoxy-Delta12,14-prostaglandin-J2 is autocatalytic and reversible. It may occur as an alternative to other cysteine modifications, such as S-nitrosylation and S-palmitoylation.

    Similarity:
    Contains 7 ANK repeats.
    Contains 1 death domain.
    Contains 1 RHD (Rel-like) domain.

    SWISS:
    P19838

    Gene ID:
    4790

    Database links:

    Entrez Gene: 4790 Human

    Omim: 164011 Human

    SwissProt: P19838 Human

    Unigene: 618430 Human



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.


    精品国产日韩亚洲一区91| 亚洲国产成人一区二区精品区 | 亚洲六月丁香婷婷综合| 亚洲国产精品一区| 久久久久久久尹人综合网亚洲| 亚洲伊人成无码综合网| 亚洲精品美女久久久久99小说| 黑人粗长大战亚洲女2021国产精品成人免费视频 | 亚洲AV无码码潮喷在线观看| 亚洲午夜久久久影院| 亚洲综合另类小说色区| 伊人久久综在合线亚洲91| 亚洲一区二区三区国产精品| 久久亚洲色一区二区三区| 久久久无码精品亚洲日韩软件| 亚洲区日韩区无码区| 国产91精品一区二区麻豆亚洲| 精品国产亚洲男女在线线电影| 91麻豆国产自产在线观看亚洲 | 久久亚洲中文字幕精品有坂深雪| 亚洲AV美女一区二区三区| 亚洲国产精品VA在线看黑人 | 77777午夜亚洲| 一本色道久久88—综合亚洲精品 | 亚洲情a成黄在线观看动漫尤物| 婷婷精品国产亚洲AV麻豆不片| 亚洲国产香蕉碰碰人人| 久久丫精品国产亚洲av不卡| 亚洲视频中文字幕在线| 亚洲午夜精品一区二区公牛电影院 | 亚洲精品国产成人| 亚洲videos| 亚洲狠狠色丁香婷婷综合| 激情无码亚洲一区二区三区 | 亚洲国产精品无码观看久久| 国产亚洲精品美女久久久久 | 亚洲精品无码成人片久久不卡| 久久人午夜亚洲精品无码区| 亚洲国产天堂久久久久久| 中文字幕精品亚洲无线码二区| 亚洲AV无码成人专区片在线观看 |